Symptomatic drugs, like cholinesterase inhibitors (e.g., donepezil) and memantine, have been the cornerstone of AD treatment for years, focusing on alleviating symptoms without altering the underlying disease progression [168,169]. The gene discussed is BCHE; the disease is Alzheimer disease.